Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after gastroenterostomy in patients with advanced pancreatic adenocarcinoma.

Sugiura T, Uesaka K, Kanemoto H, Mizuno T, Okamura Y.

Ann Surg Oncol. 2013 Dec;20(13):4330-7. doi: 10.1245/s10434-013-3227-8. Epub 2013 Aug 28.

PMID:
23982254
2.

Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass.

Espat NJ, Brennan MF, Conlon KC.

J Am Coll Surg. 1999 Jun;188(6):649-55; discussion 655-7.

PMID:
10359358
3.

Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer.

Graziosi L, Marino E, De Angelis V, Rebonato A, Cavazzoni E, Donini A.

Am J Surg. 2015 Feb;209(2):333-7. doi: 10.1016/j.amjsurg.2014.06.014. Epub 2014 Aug 5.

PMID:
25190544
4.

Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies.

Spolverato G, Maqsood H, Kim Y, Margonis G, Luo T, Ejaz A, Pawlik TM.

J Surg Oncol. 2015 Jun;111(7):868-74. doi: 10.1002/jso.23900. Epub 2015 Apr 10.

PMID:
25865111
5.

[Surgical palliation for pancreatic cancer. The 25-year experience of a single reference centre].

Popiela T, Kedra B, Sierzega M, Kubisz A.

Zentralbl Chir. 2002 Nov;127(11):965-70. German.

PMID:
12476370
6.

Unresectable pancreatic carcinoma: correlating length of survival with choice of palliative bypass.

Di Fronzo LA, Cymerman J, Egrari S, O'Connell TX.

Am Surg. 1999 Oct;65(10):955-8.

PMID:
10515542
7.

Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization.

McNally ME, Martinez A, Khabiri H, Guy G, Michaels AJ, Hanje J, Kirkpatrick R, Bloomston M, Schmidt CR.

Ann Surg Oncol. 2013 Mar;20(3):923-8. doi: 10.1245/s10434-012-2639-1. Epub 2012 Sep 11.

PMID:
22965570
8.

Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.

Tong Z, Liu L, Zheng Y, Jiang W, Zhao P, Fang W, Wang W.

World J Surg Oncol. 2017 May 30;15(1):108. doi: 10.1186/s12957-017-1169-5.

9.

Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.

Jin H, Zhang G, Liu X, Liu X, Chen C, Yu H, Huang X, Zhang Q, Yu J.

World J Surg Oncol. 2013 May 24;11:112. doi: 10.1186/1477-7819-11-112.

10.

Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.

Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, Neugut AI, Altorki NK, Abrams JA.

Ann Surg Oncol. 2011 Nov;18(12):3362-9. doi: 10.1245/s10434-011-1754-8. Epub 2011 May 6.

11.

Elevated pre-operative neutrophil to lymphocyte ratio predicts disease free survival following pancreatic resection for periampullary carcinomas.

Hamed MO, Roberts KJ, Smith AM, Morris Stiff G.

Pancreatology. 2013 Sep-Oct;13(5):534-8. doi: 10.1016/j.pan.2013.07.283. Epub 2013 Jul 31.

PMID:
24075520
12.

Preoperative Neutrophil to Lymphocyte Ratio as a Prognostic Factor in Patients with Non-metastatic Renal Cell Carcinoma.

Wen RM, Zhang YJ, Ma S, Xu YL, Chen YS, Li HL, Bai J, Zheng JN.

Asian Pac J Cancer Prev. 2015;16(9):3703-8.

13.

A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer.

Shibutani M, Maeda K, Nagahara H, Noda E, Ohtani H, Nishiguchi Y, Hirakawa K.

Anticancer Res. 2013 Aug;33(8):3291-4.

PMID:
23898094
14.

Neutrophil-lymphocyte ratio is a simple and novel biomarker for prediction of survival after radioembolization for metastatic colorectal cancer.

Tohme S, Sukato D, Chalhoub D, McDonald KA, Zajko A, Amesur N, Orons P, Marsh JW, Geller DA, Tsung A.

Ann Surg Oncol. 2015 May;22(5):1701-7. doi: 10.1245/s10434-014-4050-6. Epub 2014 Sep 5.

PMID:
25190128
16.

Prognostic Significance of Preoperative Neutrophil-Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection.

Takahashi Y, Horio H, Hato T, Harada M, Matsutani N, Morita S, Kawamura M.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1324-31. doi: 10.1245/s10434-015-4735-5. Epub 2015 Jul 22.

PMID:
26198075
17.

Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma.

Garcea G, Ladwa N, Neal CP, Metcalfe MS, Dennison AR, Berry DP.

World J Surg. 2011 Apr;35(4):868-72. doi: 10.1007/s00268-011-0984-z.

PMID:
21312035
18.
19.

Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases.

Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ, Lodge JP.

Eur J Surg Oncol. 2008 Jan;34(1):55-60. Epub 2007 Apr 19.

PMID:
17448623
20.

Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery.

Forget P, Machiels JP, Coulie PG, Berliere M, Poncelet AJ, Tombal B, Stainier A, Legrand C, Canon JL, Kremer Y, De Kock M.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S650-60. doi: 10.1245/s10434-013-3136-x. Epub 2013 Jul 25.

PMID:
23884751

Supplemental Content

Support Center